Collaboration to Elevate Virotherapy for Lung Cancer and Metastatic Solid Tumors
Monday, 10 June 2024, 08:24
Collaboration for Innovation
Calidi Biotherapeutics partners with SIGA Technologies to advance RTNova Virotherapy for lung cancer and solid tumors, aiming to revolutionize cancer therapy.
A Promising Approach
The partnership focuses on enhancing treatment options for patients, with the potential to transform cancer treatment.
- The collaboration emphasizes innovation and cutting-edge technology, paving the way for a new era in cancer therapy.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.